ANLN knockdown inhibits nasopharyngeal carcinoma proliferation and is associated with impaired ribosome biogenesis (242 — 252)
Zhengxin Zhu, Li Fu, Xue Bai, Wanqing Zhang, Songtao Liu, Hongli Min, Yuehui Liu
DOI: doi:10.4149/neo_2025_250403N151
High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K/AKT pathway (286 — 299)
Shiya Liu, Gaigai Shen, Xuanyu Zhou, Guanghui Wang, Huiqi Liu, Yuanting Cao, Lixin Sun, Xiong Shu, Yuliang Ran
DOI: doi:10.4149/neo_2025_250321N133
Temozolomide and anlotinib as second-line therapy for non-small cell lung cancer patients with brain metastases: a retrospective cohort study (300 — 306)
Kaiyan Liu, Binfeng Li, Zhengkai Xiang, Jing Tang, Xiaobing Li
DOI: doi:10.4149/neo_2025_250212N74
Shopping cart is empty
